Treatments and clinical outcomes of patients infected with SARS-CoV-2 during the first 2 weeks of admission at Mulago National Specialised Hospital and Entebbe Regional Referral Hospital
| Variable | All | Mulago National Specialised Hospital | Entebbe Regional Referral Hospital | P value |
| Treatments | n=55 | n=24 | n=31 | |
| Hydroxychloroquine, n (%) | 29 (52.7) | 0 (0.0) | 29 (93.6) | <0.001* |
| Antibiotics, n (%) | 42 (76.4) | 12 (50.0) | 30 (96.8) | <0.001* |
| Clinical outcomes at data cut-off, no (%) | ||||
| Length of hospitalisation (days) | n=47 | n=20 | n=27 | |
| Mean (SD) | 20.6 (4.1) | 19.3 (1.5) | 21.5 (5.1) | 0.068† |
| Median (IQR) | 20 (19–21) | 19 (18–20) | 21 (19–22) | 0.012‡ |
| Discharged from hospital with two negative RT-PCRs | 56 | 25 | 31 | |
| Death | 0 | 0 | 0 | |
| Admitted to intensive care unit | 0 | 0 | 0 | |
*Fisher’s exact test.
†t-Test.
‡Wilcoxon rank-sum test.
RT-PCR, reverse transcriptase PCR.